Partner, Boston Consulting Group · Los Angeles
I help senior leaders across industries (especially in MedTech and BioPharma) set ambitious growth ambitions and translate them into executable strategy at the intersection of scientific rigor, strategic judgment, and enterprise transformation.
I work with leadership teams to define credible long-term financial ambitions, prioritize competing strategic options, and build the roadmaps that translate aspiration into execution.
I help organizations move from AI interest to enterprise-level impact — connecting technology capability to operating models, value creation, and durable competitive advantage.
Deep expertise across diagnostics, genomics, life science tools, biopharma, medical devices, and health tech, grounded in a research background in translational biology.
I am a Partner at Boston Consulting Group, where I lead engagements in Corporate Finance & Strategy and Health Care. My work focuses on growth strategy, total shareholder return, innovation, and large-scale transformation — primarily with MedTech, biopharma, and life sciences companies.
I am a co-author of BCG's annual Most Innovative Companies report and bring considerable expertise in digital health, molecular diagnostics, pharmacology, data analytics, deep tech, and commercialization.
Before joining BCG, I was a research fellow in pharmacology at Baylor College of Medicine and a founder and board member of Enventure, a non-profit connecting life science entrepreneurs with educational and networking resources.
I work with CEOs, boards, and senior leadership teams. If you're navigating a complex strategic decision in healthcare or life sciences, I'm glad to connect.